ADVERTISEMENT
Search

 

Press Releases

 

17

Oct

2022

Experts flag potential risk with Paxlovid and cardiovascular drugs

Clinicians treating patients with COVID-19  who are at risk for progression to acute disease should be aware of potential drug–drug interactions when the oral antiviral treatment nirmatrelvir/ritonavir (Paxlovid—Pfizer) is administered to people taking common cardiovascular drugs, experts warn in a new Journal of the American College of Cardiology article.

Comments (0)
Number of views (13206)
Article rating: 4.1
Read more

Categories: APhA News

Tags: APhA News, COVID-19

4

Oct

2022

Courage to lead through the pandemic

FEATURES

As many student pharmacists know, direct patient care has been difficult to navigate throughout the pandemic.

Comments (0)
Number of views (811)
Article rating: No rating

31

May

2022

Celebrating unity at the APhA–ASP Opening General Session

Cheering and laughter overpowered the room as we all joined together for the APhA–ASP Opening General Session (OGS) at the APhA Annual Meeting & Exposition in March. The crowd filled with excitement as the APhA–ASP National Executive Committee stood together on stage. The journey to this moment has helped build strong relationships and longtime friendships, creating a magical experience that will not be forgotten.

Comments (0)
Number of views (871)
Article rating: No rating

9

Mar

2022

Pharmacist groups call on Biden Administration to remove limits on prescribing COVID treatments

Modification to EUAs for Oral Antivirals Needed to Achieve Potential of “Test to Treat” Initiative

Author: Renee Kalu

WASHINGTON, D.C—Today, 14 pharmacy organizations urged the Biden Administration to remove barriers preventing pharmacists from ordering oral antivirals and expand patient access to the “Test to Treat” initiative announced last week during the State of the Union.

Comments (0)
Number of views (3795)
Article rating: No rating

3

Mar

2022

President Biden’s new "Test to Treat" initiative recognizes pharmacies, but barriers should be removed

Author: Renee Kalu

WASHINGTON, D.C.—The American Pharmacists Association (APhA) made the following statement today in response to the State of the Union address on Tuesday, March 1.

Comments (0)
Number of views (5344)
Article rating: No rating
RSS
ADVERTISEMENT